<DOC>
	<DOCNO>NCT02055079</DOCNO>
	<brief_summary>Sirolimus ( SIR ) lead reduction overall kidney size , decrease cyst density general tubular cell proliferation animal model , reduction increase creatinine blood urea nitrogen 34 39 percent respectively , well reduction cyst proliferation , express 30 percent reduction overall kidney enlargement , reduction general cyst volume , reduction cyst volume density renal cortex human . However , despite promising data animal- vivo study , mammalian target rapamycin inhibitor ( mTOR-I ) study patient autosomal-dominant polycystic kidney disease ( ADPKD ) produce subtle clinically relevant effect cyst growth preservation renal function . In study investigate pulse administration SIR fix weekly oral dose 3 mg 24 month compare placebo significantly reduces cyst growth preserve excretory renal function patient ADPKD estimate glomerular filtration ( eGFR ) rate 60 mL/min per 1.73m2 .</brief_summary>
	<brief_title>Pulsed Oral Sirolimus Autosomal Dominant Polycystic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney , Autosomal Dominant</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>ADPKD , confirm history , ultrasound , compute magnetic resonance tomography Eighteen year age , old Baseline eGFR 60 mL/min per 1.73m2 Negative serum pregnancy test prior administration sirolimus agreement use contraception throughout study three month Written inform consent Need renal replacement therapy Pregnancy/lactation Plans become pregnant near future Refusal use sufficient contraception Proteinuria define protein : creatinine ratio &gt; 1000 &gt; 1g/d , respectively History life threaten complication ADPKD Evidence active systemic localize major infection Evidence infiltrate consolidation chest Xray Use investigational drug treatment 4 week prior enrolment study Known allergy/hypersensitivity sirolimus derivative Medication interfere cytochrome P450 ( CYP3A4/CYP3A5 ) system Total white blood cell count equal 3000/mm3 Platelet count equal 100.000/mm3 Fasting triglyceride equal 400 mg/dL Fasting total cholesterol equal 300 mg/dL Concomitant glomerular disease Psychiatric disorder condition might prevent full comprehension purpose risk study History malignancy , exception adequately treat basal cell squamous cell carcinoma skin HIV positivity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>ADPKD</keyword>
	<keyword>PKD</keyword>
	<keyword>Polycystic kidney disease</keyword>
	<keyword>Mammalian target rapamycin</keyword>
	<keyword>mTOR-I</keyword>
	<keyword>Sirolimus</keyword>
</DOC>